Insertion (12;9)(p13;q34q34): a cryptic rearrangement involving ABL1/ETV6 fusion in a patient with Philadelphia-negative chronic myeloid leukemia
Authors:
- 1 July 2009
- journal article
- case report
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 192 (1) , 36-39
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chronic phase of ETV6‐ABL1 positive CML responds to imatinibGenes, Chromosomes and Cancer, 2008
- Clinical and genetic studies of ETV6/ABL1‐positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylateBritish Journal of Haematology, 2003
- Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocationBlood, 2002
- Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid LeukemiaActa Haematologica, 2002
- Detection of dual TEL-ABL transcripts and a Tel-Abl protein containing phosphotyrosine in a chronic myeloid leukemia patientLeukemia, 2002
- Molecular cytogenetic and clinical findings inETV6/ABL1-positive leukemiaGenes, Chromosomes and Cancer, 2000
- The molecular biology of chronic myeloid leukemiaBlood, 2000
- BCR/ABL-negative chronic myeloid leukemia withETV6/ABL fusionGenes, Chromosomes and Cancer, 1997
- Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TELThe EMBO Journal, 1997
- Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human LeukemiaMolecular and Cellular Biology, 1996